TAK-861, TAK-861, TAK-861 clinical trials

Open-label single dose trial to evaluate pharmacokinetics, safety, and acceptability/palatability of oveporexton in children from 6 years to less than 18 years of age with narcolepsy type 1 (NT1)

This study looks at a new medicine called oveporexton for children aged 6 to 18 with narcolepsy type 1. It checks how the body handles the medicine, if it's safe, and if children find it easy to take and tasty.